Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 37.60%-28.75M | ---- | -73.10%-46.07M | ---- | -9.38%-26.62M | ---- | -219.31%-24.33M | ---- | -12.34%20.4M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | ---- | ---- | ---- | ---- | -212.01%-1.43M | ---- | 54.47%-458K | ---- | -77.11%-1.01M |
| Attributable subsidiary (profit) loss | ---- | 1,858.63%8.29M | ---- | -91.70%423K | ---- | -37.37%5.09M | ---- | 58.54%8.13M | ---- | 288.64%5.13M |
| Impairment and provisions: | ---- | -82.01%5.13M | ---- | 291.79%28.53M | ---- | -53.93%7.28M | ---- | -4.21%15.81M | ---- | --16.5M |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | 3,085.14%25.93M | ---- | -88.45%814K | ---- | --7.05M | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | ---- | ---- | ---- | ---- | 116.07%4.75M | ---- | --2.2M | ---- | ---- |
| -Impairment of goodwill | ---- | ---- | ---- | --315K | ---- | ---- | ---- | --2.13M | ---- | ---- |
| -Other impairments and provisions | ---- | 124.34%5.13M | ---- | 32.95%2.29M | ---- | -61.13%1.72M | ---- | -73.16%4.43M | ---- | --16.5M |
| Revaluation surplus: | ---- | -87.99%1M | ---- | 8,228.00%8.33M | ---- | --100K | ---- | ---- | ---- | ---- |
| -Fair value of investment properties (increase) | ---- | -87.99%1M | ---- | 8,228.00%8.33M | ---- | --100K | ---- | ---- | ---- | ---- |
| Asset sale loss (gain): | ---- | 2,789.60%3.36M | ---- | ---125K | ---- | ---- | ---- | 35.00%135K | ---- | --100K |
| -Loss (gain) from sale of subsidiary company | ---- | ---2.64M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 20.00%-100K | ---- | ---125K | ---- | ---- | ---- | 35.00%135K | ---- | --100K |
| -Loss (gain) from selling other assets | ---- | --6.1M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | ---- | 8.91%14.39M | ---- | 19.50%13.22M | ---- | -28.21%11.06M | ---- | 39.34%15.41M | ---- | 47.79%11.06M |
| -Amortization of intangible assets | ---- | ---- | ---- | -8.33%33K | ---- | -77.07%36K | ---- | -90.79%157K | ---- | -19.54%1.71M |
| Financial expense | ---- | -36.69%283K | ---- | -24.87%447K | ---- | -10.39%595K | ---- | 14.29%664K | ---- | -42.93%581K |
| Special items | ---- | -135.13%-2.83M | ---- | -127.97%-1.2M | ---- | 64.06%4.31M | ---- | 3,702.90%2.62M | ---- | -28.13%69K |
| Operating profit before the change of operating capital | ---- | -75.28%875K | ---- | 810.03%3.54M | ---- | -97.84%389K | ---- | -65.97%17.98M | ---- | 52.18%52.83M |
| Change of operating capital | ||||||||||
| Accounts payable increase (decrease) | ---- | 193.64%648K | ---- | 91.15%-692K | ---- | 10.80%-7.82M | ---- | -170.86%-8.77M | ---- | 569.74%12.37M |
| prepayments (increase)decrease | ---- | -1.03%-20.63M | ---- | -149.17%-20.42M | ---- | 325.00%41.52M | ---- | -7.87%-18.45M | ---- | -39.30%-17.11M |
| Special items for working capital changes | ---- | -148.96%-600K | ---- | 94.13%-241K | ---- | -228.53%-4.1M | ---- | 703.59%3.19M | ---- | -106.64%-529K |
| Cash from business operations | ---- | -10.64%-19.71M | ---- | -159.40%-17.81M | ---- | 595.29%29.99M | ---- | -112.73%-6.05M | ---- | 143.40%47.56M |
| Other taxs | ---- | -2,240.00%-351K | ---- | 95.71%-15K | ---- | 80.63%-350K | ---- | 75.85%-1.81M | ---- | 2.21%-7.48M |
| Interest paid - operating | ---- | 36.69%-283K | ---- | 24.87%-447K | ---- | 10.39%-595K | ---- | -14.29%-664K | ---- | 42.93%-581K |
| Special items of business | 326.80%15.43M | ---- | 45.59%-6.8M | ---- | -159.18%-12.5M | ---- | 203.84%21.13M | ---- | -249.01%-20.35M | ---- |
| Net cash from operations | 326.80%15.43M | -11.31%-20.34M | 45.59%-6.8M | -162.92%-18.27M | -159.18%-12.5M | 440.65%29.04M | 203.84%21.13M | -121.58%-8.53M | -249.01%-20.35M | 263.29%39.5M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | -39.01%705K | ---- | 2.39%1.16M | ---- | 605.63%1.13M | ---- | -77.21%160K | ---- | 142.07%702K |
| Decrease in deposits (increase) | ---- | ---- | ---- | -796.86%-4M | ---- | --574K | ---- | ---- | ---- | 1,034.41%1.06M |
| Sale of fixed assets | ---- | 451.13%733K | ---- | --133K | ---- | ---- | ---- | ---- | ---- | ---100K |
| Purchase of fixed assets | ---- | -84.82%-14.53M | ---- | 52.95%-7.86M | ---- | 34.75%-16.71M | ---- | 63.09%-25.61M | ---- | -428.62%-69.38M |
| Sale of subsidiaries | ---- | --8K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---4.5M | ---- | ---- |
| Recovery of cash from investments | ---- | --25.2M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash on investment | ---- | ---- | ---- | ---228K | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items in the investment business | -2,523.99%-7.18M | --4.66M | -73.36%296K | ---- | 121.13%1.11M | ---- | 50.61%-5.26M | ---- | -30.92%-10.65M | ---885K |
| Net cash from investment operations | -2,523.99%-7.18M | 255.40%16.78M | -73.36%296K | 28.03%-10.8M | 121.13%1.11M | 49.90%-15M | 50.61%-5.26M | 56.35%-29.95M | -30.92%-10.65M | -2,207.77%-68.61M |
| Net cash before financing | 226.85%8.25M | 87.76%-3.56M | 42.88%-6.51M | -307.12%-29.07M | -171.79%-11.39M | 136.48%14.04M | 151.20%15.87M | -32.16%-38.47M | -661.38%-30.99M | -468.48%-29.11M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | 104.50%2M | ---- | -54.23%978K | ---- | -76.26%2.14M | ---- | 68.10%9M | ---- | --5.35M |
| Refund | ---- | ---- | ---- | ---- | ---- | -68.10%-9M | ---- | 41.35%-5.35M | ---- | -2,360.38%-9.13M |
| Other items of the financing business | 10.88%-4.47M | ---- | 16.22%-5.01M | ---- | 41.50%-5.98M | --2.66M | -125.67%-10.22M | ---- | 58.49%-4.53M | ---- |
| Net cash from financing operations | 10.88%-4.47M | 19.77%-2.5M | 16.22%-5.01M | 61.00%-3.12M | 41.50%-5.98M | -866.43%-8M | -125.67%-10.22M | 90.17%-828K | 58.49%-4.53M | -92.44%-8.42M |
| Effect of rate | -91.32%132K | 90.42%-25K | 140.16%1.52M | 49.42%-261K | -145.78%-3.79M | -130.95%-516K | -565.26%-1.54M | -58.12%1.67M | -85.91%331K | 194.67%3.98M |
| Net Cash | 132.90%3.79M | 81.17%-6.06M | 33.70%-11.52M | -633.51%-32.19M | -407.69%-17.37M | 115.35%6.03M | 115.89%5.65M | -4.71%-39.3M | -558.83%-35.52M | -1,165.01%-37.53M |
| Begining period cash | -14.93%34.68M | -44.33%40.76M | -48.49%40.76M | 8.15%73.21M | 16.90%79.14M | -35.73%67.7M | -35.73%67.7M | -24.16%105.33M | -24.16%105.33M | -0.49%138.88M |
| Cash at the end | 25.46%38.6M | -14.93%34.68M | -46.94%30.76M | -44.33%40.76M | -19.25%57.98M | 8.15%73.21M | 2.38%71.8M | -35.73%67.7M | -48.37%70.14M | -24.16%105.33M |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --70.14M | ---- |
| Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --70.14M | ---- |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Beijing Xinghua Dingfeng Certified Public Accountants Co., Ltd. | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.